Meg Samek-Smith

About Meg Samek-Smith

I am passionate about advancing personalized medicine and transforming healthcare from reactive sickcare to proactive, true healthcare that improves lives at scale.As a proven business builder, I have founded and led multiple companies, including one that achieved a successful $100 million exit. This track record demonstrates my ability to generate significant value through innovative thinking, strategic planning, and effective execution.I am the Founder, CEO, and Editor-in-Chief of Genomics Media Group, a business media company dedicated solely to the genomics industry. Our mission is to become the Bloomberg of Genomics by delivering data-driven, insightful coverage that empowers investors, industry leaders, and scientists worldwide.I also serve as President and Chief Revenue Officer at MultiplAI Health, driving growth and commercialization of an RNA and AI-based platform that pioneers ultra-early disease detection. I leverage my MBA and deep expertise in genomics, healthcare, and biotech to lead capital strategy, operational scaling, and market expansion efforts.In addition to my executive roles, I actively serve as a Board Member and Techstars Mentor, supporting emerging biotech innovators to navigate growth and commercialization challenges. These roles reflect my commitment to bridging cutting-edge science with real-world impact, helping translate breakthrough innovations into scalable solutions.The common thread between all these roles is a dedication to ushering in a new era of personalized, preventative healthcare.

Experience

1. Co-founder, Chief Executive Officer & Editor-in-chief

   Genomics Media Group

   Jan 2025 — Present

   Our goal is to become ‘The Bloomberg of Genomics’ - the first major business media company solely dedicated to genomics business news. We aim to do this through insightful, global reporting of the financial aspects of the emerging genomics industry, powered by data. We are not a scientific publisher, not a general business website, not merely another newsletter, and we are more than a podcast. We are All business, All genomics, All the time. Our headquarters are located in Maryland, long associated with genetic research. We also have AI-driven research in San Diego, near the Scripps Research Institute (TSRI) Genomics Core Facility which has provided cutting-edge genomic technologies since the emergence of the field.

Education

• Thunderbird School of Global Management

  Master of Business Administration - MBA

• Bucknell University

  Bachelor of Arts, International Relations & French Language